These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 807407)

  • 1. [Sensitivity and resistance of Candida to 5-fluorocytosine. Relationship to the cell wall ultrastructure].
    Montplaisir S; Drouhet E; Nabarra B
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(19):2211-3. PubMed ID: 807407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility and resistance of Candida to 5-fluorocytosine in relation to the cell wall ultrastructure.
    Montplaisir S; Nabarra B; Drouhet E
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1028-32. PubMed ID: 945713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. I.--Relation between the phenotypes of resistance to 5-fluorocytosine, the serotype of Candida albicans and the ecology of various species of Candida of human origin (author's transl)].
    Drouhet E; Mercier-Soucy L; Montplaisir S
    Ann Microbiol (Paris); 1975; 126B(1):25-39. PubMed ID: 1108732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M; Winblad B; Anséhn S; Schönebeck J
    Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G; Sobral T; Ferreira AF
    Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH; Sarosi GA
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Markie D; Kwon-Chung KJ
    Antimicrob Agents Chemother; 1986 May; 29(5):726-9. PubMed ID: 3524427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological changes in yeasts as a result of the action of 5-fluorocytosine.
    Arai T; Mikami Y; Yokoyama K; Kawata T; Masuda K
    Antimicrob Agents Chemother; 1977 Aug; 12(2):255-60. PubMed ID: 332075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action mechanism of 5-fluorocytosine. IV. Morphological observation and development of the resistant cells].
    Arai T; Mikami Y; Kawada T; Masuda K
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):257. PubMed ID: 765563
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Normark S; Schönebeck J
    Antimicrob Agents Chemother; 1972 Sep; 2(3):114-21. PubMed ID: 4597703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segregation of 5-fluorocytosine-resistance variants by Candida albicans.
    Whelan WL; Beneke ES; Rogers AL; Soll DR
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1078-81. PubMed ID: 7023383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of yeasts against 5 fluorocytosine. Comparison of five methods (author's transl)].
    Brinkmann F
    Z Hautkr; 1981 Oct; 56(19):1255-63. PubMed ID: 7032101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
    Polak A; Wain WH
    Chemotherapy; 1977; 23(4):243-59. PubMed ID: 324722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W
    Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.
    Defever KS; Whelan WL; Rogers AL; Beneke ES; Veselenak JM; Soll DR
    Antimicrob Agents Chemother; 1982 Nov; 22(5):810-5. PubMed ID: 6758690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.
    Di Vito M; Podo F; Torosantucci A; Carpinelli G; Whelan WL; Kerridge D; Cassone A
    Antimicrob Agents Chemother; 1986 Feb; 29(2):303-8. PubMed ID: 3521476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.